SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-048151
Filing Date
2021-12-14
Accepted
2021-12-14 17:32:58
Documents
1
Period of Report
2021-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6173
  Complete submission text file 0000899243-21-048151.txt   8285
Mailing Address 4160 DUBLIN BLVD., SUITE 200 DUBLIN CA 94568
Business Address
Appelbaum Kevin J (Reporting) CIK: 0001547557 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39864 | Film No.: 211492118

Mailing Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036
Business Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036 646-493-6558
Better Therapeutics, Inc. (Issuer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1028
SIC: 8000 Services-Health Services

Mailing Address 548 MARKET STREET, #49404 SAN FRANCISCO CA 94104
Business Address 548 MARKET STREET, #49404 SAN FRANCISCO CA 94104 415.887.2311
Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended (Reporting) CIK: 0001890904 (see all company filings)

State of Incorp.: OR | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39864 | Film No.: 211492117